Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
DexCom, Inc. (DXCM - Free Report) medical device company that focuses on design, development, and commercialization of continuous glucose monitoring systems. The Zacks Consensus Estimate for its current year earnings has been revised 1.8% downward over the last 30 days.
GreenPower Motor Company Inc. (GP - Free Report) designs, manufactures, and distributes electric vehicles. The Zacks Consensus Estimate for its current year earnings has been revised 43.5% downward over the last 30 days.
Phreesia, Inc. (PHR - Free Report) provides an integrated SaaS-based software and payment platform. The Zacks Consensus Estimate for its current year earnings has been revised 22.9% downward over the last 30 days.
Rite Aid Corporation operates as a chain of retail drugstores. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Maxar Technologies Inc. provides earth intelligence and space infrastructure solutions. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
DexCom, Inc. (DXCM - Free Report) medical device company that focuses on design, development, and commercialization of continuous glucose monitoring systems. The Zacks Consensus Estimate for its current year earnings has been revised 1.8% downward over the last 30 days.
GreenPower Motor Company Inc. (GP - Free Report) designs, manufactures, and distributes electric vehicles. The Zacks Consensus Estimate for its current year earnings has been revised 43.5% downward over the last 30 days.
Phreesia, Inc. (PHR - Free Report) provides an integrated SaaS-based software and payment platform. The Zacks Consensus Estimate for its current year earnings has been revised 22.9% downward over the last 30 days.
Rite Aid Corporation operates as a chain of retail drugstores. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Maxar Technologies Inc. provides earth intelligence and space infrastructure solutions. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DXCM - FREE
Get the latest research report on GP - FREE
Get the latest research report on PHR - FREE